Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
Study NCT ID:
NCT01676818
Status:
COMPLETED
Last Update Posted:
2025-11-06
First Post:
2012-08-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
Sponsor:
University of Southern California
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-29
First Submit QC Date:
None
Study First Post Date:
2012-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-10-10
Results First Submit QC Date:
None
Results First Post Date:
2025-11-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-28
Last Update Post Date:
2025-11-06
Last Update Post Date Type:
ESTIMATED